Vaccine Immunology

This track focuses on the immunological principles underlying vaccine-induced protection. It explores how innate and adaptive immune responses are activated by vaccines and how immune memory is established and maintained. Sessions will address antigen recognition, immune correlates of protection, adjuvant mechanisms, and host factors influencing vaccine efficacy. Emphasis will be placed on translating immunological insights into improved vaccine design, effectiveness, and safety across diverse populations.

Therapeutic and Cancer Vaccines

This track focuses on the development and clinical application of therapeutic vaccines designed to treat established diseases, including cancer. It highlights advances in tumor antigens, immune-based therapies, personalized vaccine approaches, and strategies to enhance antitumor immune responses. Sessions will address translational research, clinical trials, and emerging technologies shaping therapeutic vaccination.

Global Vaccine Initiatives

This track focuses on international efforts to improve vaccine access, coverage, and equity. It highlights strategies for implementing immunization programs, policy development, public health planning, and collaborative efforts to control vaccine-preventable diseases worldwide. Sessions will cover lessons from large-scale vaccination campaigns, global partnerships, and strategies to reach underserved populations.

Next-Gen Vaccine Research

This track focuses on cutting-edge approaches in vaccine development, including novel platforms, advanced antigen design, and innovative delivery systems. Discussions will cover mRNA vaccines, viral vectors, nanoparticle technologies, and strategies to improve immunogenicity and safety. Emphasis will be placed on translating scientific discoveries into next-generation vaccines for emerging and re-emerging infectious diseases.

Maternal, Child & Elderly Vaccines

This track focuses on vaccination strategies for vulnerable populations, including infants, children, pregnant women, and the elderly. It covers age-specific immunization schedules, maternal immunization, booster strategies, and approaches to enhance vaccine coverage and protection in high-risk groups.

Vaccine Delivery

This track focuses on innovative methods and devices for vaccine administration, including needle-free systems, micro-needle patches, oral formulations, and advanced delivery platforms. Discussions will cover strategies to improve vaccine stability, efficacy, accessibility, and patient compliance.

Needle-Free Vaccines

This track focuses on non-invasive vaccine delivery methods that eliminate the use of needles. It includes mucosal, oral, intranasal, transdermal, and microneedle approaches. Sessions will cover strategies to improve patient compliance, vaccine stability, immune response, and accessibility for mass immunization programs.

Veterinary and Animal Health Vaccines

This track focuses on the development and application of vaccines for livestock, pets, and wildlife. It covers disease prevention, immunization strategies, vaccine safety, and emerging technologies to protect animal health and support food security.

Drug-Resistant Pathogen Vaccines

This track focuses on the development and evaluation of vaccines targeting drug-resistant bacterial, viral, and fungal pathogens. It highlights strategies to prevent infections, reduce antimicrobial resistance, and improve global health outcomes. Sessions will cover novel vaccine platforms, immune responses, and translational approaches to combat resistant pathogens.

Vaccine Production & Scale-Up

This track focuses on the processes involved in manufacturing vaccines at clinical and commercial scale. Topics include bioprocess development, upstream and downstream processing, quality control, technology transfer, and strategies for efficient and reliable large-scale vaccine production.

AI-Driven Vaccine Design

This track focuses on the application of artificial intelligence and machine learning to accelerate vaccine discovery and development. It covers computational modeling, antigen prediction, immune response analysis, and data-driven approaches that support efficient and targeted vaccine design.

Vaccine Safety and Pharmacovigilance

This track addresses the monitoring and evaluation of vaccine safety throughout development and post-licensure use. Topics include adverse event assessment, risk management, surveillance systems, and the use of real-world data to support safe and effective immunization programs

Multi-Antigen Vaccines

This track focuses on vaccines designed to target multiple antigens or pathogens within a single formulation. It covers strategies for antigen selection, formulation design, immune response optimization, and clinical evaluation to improve protection and streamline immunization schedules.

Vaccines for Pandemic Response

This track focuses on strategies for rapid vaccine development, evaluation, and deployment during infectious disease outbreaks. It covers platform technologies, emergency clinical trials, regulatory pathways, and coordinated responses to emerging public health threats.

Temperature-Stable Vaccines

This track focuses on vaccine formulations and technologies designed to maintain stability and efficacy under variable temperature conditions. Topics include formulation strategies, stabilization techniques, and approaches that reduce reliance on cold chain systems to improve vaccine access and distribution.

Biomarkers in Vaccine Development

This track focuses on the identification and application of biomarkers to assess vaccine efficacy, safety, and immune responses. It covers immune correlates of protection, predictive markers, and analytical tools that support vaccine design, clinical evaluation, and regulatory decision-making.

Vaccine Regulatory Science

This track addresses the regulatory frameworks and scientific principles guiding vaccine development, evaluation, and approval. Topics include regulatory requirements, clinical trial oversight, quality standards, and post-approval monitoring to ensure vaccine safety, efficacy, and compliance.

Vaccinology and Genomics

This track focuses on the integration of genomic and systems-level data to inform vaccine discovery and evaluation. Topics include pathogen genomics, host genetic factors, omics technologies, and data-driven approaches that support vaccine design, immune profiling, and precision immunization strategies.

Clinical Vaccinology

This track focuses on the clinical evaluation, implementation, and real-world performance of vaccines. It covers clinical trial design, immunogenicity assessment, vaccine effectiveness, safety monitoring, and evidence-based strategies to optimize immunization programs.

Post-Marketing Vaccine Safety

This track focuses on monitoring and evaluating vaccine safety after approval and widespread use. Topics include adverse event reporting, pharmacovigilance systems, risk assessment, real-world data analysis, and strategies to ensure ongoing vaccine safety and public confidence.